table of content
1 Study Coverage
1.1 TB Vaccines Product Introduction
1.2 Global TB Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global TB Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global TB Vaccines Sales in Volume for the Year 2017-2028
1.3 United States TB Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States TB Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States TB Vaccines Sales in Volume for the Year 2017-2028
1.4 TB Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States TB Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of TB Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 TB Vaccines Market Dynamics
1.5.1 TB Vaccines Industry Trends
1.5.2 TB Vaccines Market Drivers
1.5.3 TB Vaccines Market Challenges
1.5.4 TB Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 TB Vaccines Market Segment by Type
2.1.1 Immunotherapeutic Vaccines
2.1.2 Booster Vaccines
2.1.3 Others
2.2 Global TB Vaccines Market Size by Type
2.2.1 Global TB Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global TB Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global TB Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States TB Vaccines Market Size by Type
2.3.1 United States TB Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States TB Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States TB Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 TB Vaccines Market Segment by Application
3.1.1 Hospitals
3.1.2 Private Clinics
3.1.3 Research Institutes
3.2 Global TB Vaccines Market Size by Application
3.2.1 Global TB Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global TB Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global TB Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States TB Vaccines Market Size by Application
3.3.1 United States TB Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States TB Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States TB Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global TB Vaccines Competitor Landscape by Company
4.1 Global TB Vaccines Market Size by Company
4.1.1 Top Global TB Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global TB Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global TB Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global TB Vaccines Price by Manufacturer (2017-2022)
4.2 Global TB Vaccines Concentration Ratio (CR)
4.2.1 TB Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of TB Vaccines in 2021
4.2.3 Global TB Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global TB Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global TB Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers TB Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into TB Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States TB Vaccines Market Size by Company
4.5.1 Top TB Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States TB Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States TB Vaccines Sales by Players (2020, 2021 & 2022)
5 Global TB Vaccines Market Size by Region
5.1 Global TB Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global TB Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global TB Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global TB Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global TB Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global TB Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global TB Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America TB Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America TB Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific TB Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific TB Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe TB Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe TB Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America TB Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America TB Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa TB Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa TB Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Merck & Co.,Inc
7.1.1 Merck & Co.,Inc Corporation Information
7.1.2 Merck & Co.,Inc Description and Business Overview
7.1.3 Merck & Co.,Inc TB Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Merck & Co.,Inc TB Vaccines Products Offered
7.1.5 Merck & Co.,Inc Recent Development
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Corporation Information
7.2.2 Sanofi Pasteur Description and Business Overview
7.2.3 Sanofi Pasteur TB Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Sanofi Pasteur TB Vaccines Products Offered
7.2.5 Sanofi Pasteur Recent Development
7.3 Japan BCG Laboratory
7.3.1 Japan BCG Laboratory Corporation Information
7.3.2 Japan BCG Laboratory Description and Business Overview
7.3.3 Japan BCG Laboratory TB Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Japan BCG Laboratory TB Vaccines Products Offered
7.3.5 Japan BCG Laboratory Recent Development
7.4 China National Biotec Group
7.4.1 China National Biotec Group Corporation Information
7.4.2 China National Biotec Group Description and Business Overview
7.4.3 China National Biotec Group TB Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 China National Biotec Group TB Vaccines Products Offered
7.4.5 China National Biotec Group Recent Development
7.5 Serum Institute
7.5.1 Serum Institute Corporation Information
7.5.2 Serum Institute Description and Business Overview
7.5.3 Serum Institute TB Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Serum Institute TB Vaccines Products Offered
7.5.5 Serum Institute Recent Development
7.6 India Pvt. Ltd
7.6.1 India Pvt. Ltd Corporation Information
7.6.2 India Pvt. Ltd Description and Business Overview
7.6.3 India Pvt. Ltd TB Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 India Pvt. Ltd TB Vaccines Products Offered
7.6.5 India Pvt. Ltd Recent Development
7.7 InterVax Ltd
7.7.1 InterVax Ltd Corporation Information
7.7.2 InterVax Ltd Description and Business Overview
7.7.3 InterVax Ltd TB Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 InterVax Ltd TB Vaccines Products Offered
7.7.5 InterVax Ltd Recent Development
7.8 GreenSignal
7.8.1 GreenSignal Corporation Information
7.8.2 GreenSignal Description and Business Overview
7.8.3 GreenSignal TB Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 GreenSignal TB Vaccines Products Offered
7.8.5 GreenSignal Recent Development
7.9 Bio Pharma Limited
7.9.1 Bio Pharma Limited Corporation Information
7.9.2 Bio Pharma Limited Description and Business Overview
7.9.3 Bio Pharma Limited TB Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Bio Pharma Limited TB Vaccines Products Offered
7.9.5 Bio Pharma Limited Recent Development
7.10 Statens Serum Institut
7.10.1 Statens Serum Institut Corporation Information
7.10.2 Statens Serum Institut Description and Business Overview
7.10.3 Statens Serum Institut TB Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Statens Serum Institut TB Vaccines Products Offered
7.10.5 Statens Serum Institut Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 TB Vaccines Industry Chain Analysis
8.2 TB Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 TB Vaccines Distributors
8.3 TB Vaccines Production Mode & Process
8.4 TB Vaccines Sales and Marketing
8.4.1 TB Vaccines Sales Channels
8.4.2 TB Vaccines Distributors
8.5 TB Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
